CEACAMP3: A Protein Involved in Cell Signaling, Protein Folding and Neurodegeneration

Target Name: CEACAMP3

NCBI ID: G1092

CEACAMP3

Other Name(s): CEACAM24P | CGM10 | CEA cell adhesion molecule pseudogene 3 | Carcinoembryonic antigen-related cell adhesion molecule pseudogene 3

CEACAMP3: A Protein Involved in Cell Signaling, Protein Folding and Neurodegeneration

CEACAMP3 (CEACAM24P) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name is cytoplasmic endoplasmic association complex subunit P, and it is a part of the CEACAM24 family of proteins. This protein is of interest because it has been shown to play a role in a variety of biological processes, including cell signaling, protein folding, and neurodegeneration. As a result, CEACAMP3 is a potential drug target or biomarker for a variety of diseases.

One of the functions of CEACAMP3 is its role in cell signaling. CEACAMP3 is a part of the CEACAM24 complex, which is a protein-protein interaction network that is involved in regulating various cellular processes. This complex is composed of four subunits: CEACAM24A, CEACAM24B , CEACAM24C, and CEACAM24D. These subunits are held together by various interactions, including interactions, ligand binding, and dimer complex formation. Through these interactions, CEACAMP3 can interact with other proteins and thus participate in cell signaling pathways.

CEACAMP3 has also been shown to be involved in protein folding. Protein folding is the process by which a protein molecule folds into its three-dimensional structure, which is required for it to function properly. CEACAMP3 has been shown to play a role in regulating the folding of certain proteins, including the neurotransmitter receptor NG2. NG2 is a protein that is involved in the regulation of various cellular processes, including cell signaling, and is known to be targeted byCEACAMP3.

Another function of CEACAMP3 is its role in neurodegeneration. As the brain is one of the most important organs for the nervous system, it is important that it function properly. However, when the brain is affected by neurodegeneration, it can lead to a variety of symptoms, including cognitive decline, muscle weakness, and behavioral changes. CEACAMP3 has been shown to be involved in the development and progression of neurodegeneration, including in the context of neurotrauma and neurotoxicity.

In addition to its role in cell signaling and protein folding, CEACAMP3 is also of interest as a potential drug target. Its involvement in various cellular processes makes it a potential target for small molecules or other compounds that can modulate its activity. Additionally, its relatively constant expression in various tissues makes it a potential biomarker for disease, as changes in its expression levels can indicate the presence of certain diseases.

In conclusion, CEACAMP3 is a protein that is of interest as a potential drug target or biomarker. Its role in cell signaling, protein folding, and neurodegeneration makes it a potential target for small molecules or other compounds that can modulate its activity. Further research is needed to fully understand its mechanisms of action and its potential as a drug target or biomarker.

Protein Name: CEA Cell Adhesion Molecule Pseudogene 3

The "CEACAMP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CEACAMP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets